• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed

    2/12/21 4:17:07 PM ET
    $AGTC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $AGTC alert in real time by email
    SC 13G/A 1 d133830dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

     

     

    Applied Genetic Technologies Corporation

    (Name of Issuer)

    Common Stock, $0.001 par value per share

    (Title of Class of Securities)

    03820J100

    (CUSIP Number)

    December 31, 2020

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☒ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing of this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

     

     

     


      1.    

      Name of Reporting Person

      I.R.S. Identification No. of Above Person (Entities Only)

     

      Intersouth Partners VI, L.P.

      2.    

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3.    

      SEC Use Only

     

      4.    

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

      Beneficially  

    Owned By

    Each

    Reporting

    Person

    with

        5.     

      Sole Voting Power

     

      0

      6.     

      Shared Voting Power

     

      1,214,457

      7.     

      Sole Dispositive Power

     

      0

      8.     

      Shared Dispositive Power

     

      1,214,457

      9.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      1,214,457

    10.    

      Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11.    

      Percent of Class Represented by Amount in Row (9)

     

      4.7%(1)

    12.    

      Type of Reporting Person

     

      PN

     

    1 

    This percentage is calculated based upon 25,889,625 shares of common stock outstanding on November 11, 2020 as reported by Applied Genetic Technologies Corporation (the “Issuer”) on its Form 10-Q for the quarterly period ended September 30, 2020 (the Form 10-Q”) as filed with the Securities and Exchange Commission (the “SEC”) on November 16, 2020.

     

    2


      1.    

      Name of Reporting Person

      I.R.S. Identification No. of Above Person (Entities Only)

     

      Intersouth Associates VI, LLC

      2.    

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3.    

      SEC Use Only

     

      4.    

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

      Beneficially  

    Owned By

    Each

    Reporting

    Person

    with

        5.     

      Sole Voting Power

     

      0

      6.     

      Shared Voting Power

     

      1,214,457

      7.     

      Sole Dispositive Power

     

      0

      8.     

      Shared Dispositive Power

     

      1,214,457

      9.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      1,214,457

    10.    

      Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11.    

      Percent of Class Represented by Amount in Row (9)

     

      4.7%(2)

    12.    

      Type of Reporting Person

     

      00

     

     

    2 

    This percentage is calculated based upon 25,889,625 shares of common stock outstanding on November 11, 2020 as reported by the Issuer on its Form 10-Q as filed with the SEC on November 16, 2020.

     

    3


      1.    

      Name of Reporting Person

      I.R.S. Identification No. of Above Person (Entities Only)

     

      Dennis Dougherty

      2.    

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3.    

      SEC Use Only

     

      4.    

      Citizenship or Place of Organization

     

      United States of America

    Number of

    Shares

      Beneficially  

    Owned By

    Each

    Reporting

    Person

    with

        5.     

      Sole Voting Power

     

      0

      6.     

      Shared Voting Power

     

      1,214,457

      7.     

      Sole Dispositive Power

     

      0

      8.     

      Shared Dispositive Power

     

      1,214,457

      9.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      1,214,457

    10.    

      Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11.    

      Percent of Class Represented by Amount in Row (9)

     

      4.7%(3)

    12.    

      Type of Reporting Person

     

      IN

     

     

    3 

    This percentage is calculated based upon 25,889,625 shares of common stock outstanding on November 11, 2020 as reported by the Issuer on its Form 10-Q as filed with the SEC on November 16, 2020.

     

    4


      1.    

      Name of Reporting Person

      I.R.S. Identification No. of Above Person (Entities Only)

     

      Mitch Mumma

      2.    

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3.    

      SEC Use Only

     

      4.    

      Citizenship or Place of Organization

     

      United States of America

    Number of

    Shares

      Beneficially  

    Owned By

    Each

    Reporting

    Person

    with

        5.     

      Sole Voting Power

     

      0

      6.     

      Shared Voting Power

     

      1,214,457

      7.     

      Sole Dispositive Power

     

      0

      8.     

      Shared Dispositive Power

     

      1,214,457

      9.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      1,214,457

    10.    

      Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11.    

      Percent of Class Represented by Amount in Row (9)

     

      4.7%(4)

    12.    

      Type of Reporting Person

     

      IN

     

     

    4 

    This percentage is calculated based upon 25,889,625 shares of common stock outstanding on November 11, 2020 as reported by the Issuer on its Form 10-Q as filed with the SEC on November 16, 2020.

     

    5


    Item 1(a)

    Name of Issuer

    Applied Genetic Technologies Corporation (the “Issuer”)

     

    Item 1(b)

    Address of Issuer’s Principal Executive Offices

    11801 Research Drive, Suite D

    Alachua, Florida 32615

     

    Item 2(a)

    Name of Persons Filing

    Intersouth Partners VI, L.P. (“ISP VI”)

    Intersouth Associates VI, LLC (“ISA VI, LLC”)

    Dennis Dougherty

    Mitch Mumma (together with ISP VI, ISA VI, LLC, and Mr. Dougherty, the “Reporting Persons”).

     

    Item 2(b)

    Address of Principal Business Office, or if none, Residence

    For each of the Reporting Persons:

    c/o Intersouth Partners

    4711 Hope Valley Road

    Suite 4F - 632

    Durham, North Carolina 27707

     

    Item 2(c)

    Citizenship

    ISP VI – Delaware limited partnership

    ISA VI, LLC – Delaware limited liability company

    Dennis Dougherty – United States of America

    Mitch Mumma – United States of America

     

    Item 2(d)

    Title of Class of Securities

    Common Stock, $0.001 par value per share

     

    Item 2(e)

    CUSIP Number

    03820J100

     

    Item 3.

    Filing pursuant to Rules 13d-1(b) or 13d-2(b) or (c)

    Not Applicable

     

    Item 4.

    Ownership

     

      (a)

    Amount Beneficially Owned

     

    6


    The Reporting Persons are the owners of an aggregate of 1,214,457 shares of Common Stock, which represents 4.7% of the Issuer’s outstanding common stock based upon 25,889,625 shares of common stock outstanding on November 11, 2020 as reported on its form 10-Q as filed with the SEC on November 16, 2020. ISP VI directly beneficially owns 1,214,457 shares of Common Stock, or 4.7% of the Issuer’s common stock outstanding. ISA VI, LLC, as the general partner of ISP VI, may be deemed to indirectly beneficially own the securities owned by ISP VI. Messrs. Dougherty and Mumma, as Member Managers of ISA VI, LLC, may be deemed to indirectly beneficially own the securities owned by ISP VI.

    Each of (i) ISP VI, (ii) ISA VI, LLC, and (iii) Messrs. Dougherty and Mumma, may be deemed to share the power to vote or direct the voting of, and to dispose or direct the disposition of, the securities of Issuer that are directly beneficially owned by ISP VI. Each of Messrs. Dougherty and Mumma disclaims beneficial ownership of all securities other than those he owns by virtue of his indirect pro rata interest as a member of ISA VI, LLC.

     

      (b)

    Percent of Class

    ISP VI – 4.7%

    ISA VI, LLC – 4.7%

    Mitch Mumma – 4.7%

    Dennis Dougherty – 4.7%

    The above percentages are based on 25,889,625 shares of common stock outstanding on November 11, 2020 as reported on its form 10-Q as filed with the SEC on November 16, 2020.

     

      (c)

    Number of shares as to which the person has;

     

      (i)

    sole power to vote or direct the vote:

    ISP VI – 0

    ISA VI, LLC – 0

    Mitch Mumma – 0

    Dennis Dougherty - 0

     

      (ii)

    shared power to vote or direct the vote:

    ISP VI - 1,214,457

    ISA VI, LLC – 1,214,457

    Mitch Mumma – 1,214,457

    Dennis Dougherty – 1,214,457

    (See Item 4(a))

     

      (iii)

    sole power to dispose or direct the disposition of:

    ISP VI – 0

    ISA VI, LLC – 0

    Mitch Mumma – 0

    Dennis Dougherty - 0

     

    7


      (iv)

    shared power to dispose or direct the disposition of:

    ISP VI - 1,214,457

    ISA VI, LLC – 1,214,457

    Mitch Mumma – 1,214,457

    Dennis Dougherty – 1,214,457

    (See Item 4(a))

     

    Item 5.

    Ownership of Five Percent or Less of a Class

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ☒

     

    Item 6.

    Ownership of More than Five Percent on Behalf of Another Person

    Not Applicable

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

    Not Applicable.

     

    Item 8.

    Identification and Classification of Members of the Group

    Not Applicable.

     

    Item 9.

    Notice of Dissolution of Group

    Not Applicable

     

    Item 10.

    Certification

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

    Exhibit Index

    Exhibit A – Joint Filing Agreement is incorporated by reference to Exhibit A included in the Schedule 13G filed by the Reporting Persons on April 28, 2014.

     

    8


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement with respect to such person is true, complete and correct.

    Date:    February 12, 2021

     

    INTERSOUTH PARTNERS VI, L.P.

    By:  

    Intersouth Associates VI, LLC

    its General Partner

    By:  

    /s/ Dennis Dougherty

    Name:   Dennis Dougherty
    Title:   Member Manager
    INTERSOUTH ASSOCIATES VI, L.P.
    By: Intersouth Associates VI, LLC its General Partner
    By:  

    /s/ Mitch Mumma

    Name:   Mitch Mumma
    Title:   Member Manager

    /s/ Dennis Dougherty

    Dennis Dougherty

    /s/ Mitch Mumma

    Mitch Mumma

     

    9

    Get the next $AGTC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AGTC

    DatePrice TargetRatingAnalyst
    More analyst ratings